GarvanInstitute's profile picture. We see a future where we’re able to stop disease before it starts.

Garvan Institute of Medical Research

@GarvanInstitute

We see a future where we’re able to stop disease before it starts.

Stella was born with a rare immune disease causing severe skin infections. Her dad, Nico, reflects on the impact of her diagnosis, delivered by Garvan’s CIRCA program🩺. Help us connect more people like Stella with a life-changing diagnosis: ow.ly/Aczu50Xqi4h


🎧 For decades, cancer research has focused on killing the tumour cell. In this episode, Dr Ankur Sharma delves into the critical insight that cancer is not just a rogue cell – it’s an entire ecosystem – and that ecosystem is the key to unlocking a new class of cures.


Diagnosed with coeliac disease at 59, Mark went gluten-free but symptoms persisted. Our research revealed why. "Knowing there was a reason – it wasn't in my head – changed everything," he says. ow.ly/Kne850XqPWA

GarvanInstitute's tweet image. Diagnosed with coeliac disease at 59, Mark went gluten-free but symptoms persisted. Our research revealed why. "Knowing there was a reason – it wasn't in my head – changed everything," he says. ow.ly/Kne850XqPWA
GarvanInstitute's tweet image. Diagnosed with coeliac disease at 59, Mark went gluten-free but symptoms persisted. Our research revealed why. "Knowing there was a reason – it wasn't in my head – changed everything," he says. ow.ly/Kne850XqPWA
GarvanInstitute's tweet image. Diagnosed with coeliac disease at 59, Mark went gluten-free but symptoms persisted. Our research revealed why. "Knowing there was a reason – it wasn't in my head – changed everything," he says. ow.ly/Kne850XqPWA

A major milestone: Garvan’s CIRCA program has cut hospital stays for people with rare immune diseases from an average of 68 days to just 5! However, most patients are still waiting for answers. Help us deliver even more life-changing diagnoses: ow.ly/RtZg50XqgAN

GarvanInstitute's tweet image. A major milestone: Garvan’s CIRCA program has cut hospital stays for people with rare immune diseases from an average of 68 days to just 5! However, most patients are still waiting for answers. Help us deliver even more life-changing diagnoses: ow.ly/RtZg50XqgAN

Bev has lived most of her life in a body she doesn’t fully understand. After decades of unexplained symptoms, she is still searching for answers. To read Bev’s story, click here: garvan.org.au/impact/stories…

GarvanInstitute's tweet image. Bev has lived most of her life in a body she doesn’t fully understand. After decades of unexplained symptoms, she is still searching for answers.

To read Bev’s story, click here: garvan.org.au/impact/stories…
GarvanInstitute's tweet image. Bev has lived most of her life in a body she doesn’t fully understand. After decades of unexplained symptoms, she is still searching for answers.

To read Bev’s story, click here: garvan.org.au/impact/stories…

Pancreatic cancer affects thousands of Australian families. This November, we're spotlighting Garvan's research and scientists working towards a future where pancreatic cancer is no longer a 'silent' threat. 💜 Find out more: garvan.org.au/research/disea…

GarvanInstitute's tweet image. Pancreatic cancer affects thousands of Australian families. This November, we're spotlighting Garvan's research and scientists working towards a future where pancreatic cancer is no longer a 'silent' threat. 💜
Find out more: garvan.org.au/research/disea…
GarvanInstitute's tweet image. Pancreatic cancer affects thousands of Australian families. This November, we're spotlighting Garvan's research and scientists working towards a future where pancreatic cancer is no longer a 'silent' threat. 💜
Find out more: garvan.org.au/research/disea…
GarvanInstitute's tweet image. Pancreatic cancer affects thousands of Australian families. This November, we're spotlighting Garvan's research and scientists working towards a future where pancreatic cancer is no longer a 'silent' threat. 💜
Find out more: garvan.org.au/research/disea…
GarvanInstitute's tweet image. Pancreatic cancer affects thousands of Australian families. This November, we're spotlighting Garvan's research and scientists working towards a future where pancreatic cancer is no longer a 'silent' threat. 💜
Find out more: garvan.org.au/research/disea…

We’ve found a new mutation causing APECED, an autoimmune condition affecting hormone-producing organs and causing fungal infections. This single-copy mutation causes a milder form – without recurrent thrush. This could speed up diagnosis & treatment. ow.ly/lXls50Xlx6M

GarvanInstitute's tweet image. We’ve found a new mutation causing APECED, an autoimmune condition affecting hormone-producing organs and causing fungal infections.
This single-copy mutation causes a milder form – without recurrent thrush. This could speed up diagnosis & treatment. ow.ly/lXls50Xlx6M

For 18 months, Stella's family searched desperately for answers to her severe, recurrent infections. Finally, the team at CIRCA helped diagnose her with a rare immune disease. 🩺 👉 Help us find answers for families like Stella’s: ow.ly/f7xA50XjskH

GarvanInstitute's tweet image. For 18 months, Stella's family searched desperately for answers to her severe, recurrent infections. Finally, the team at CIRCA helped diagnose her with a rare immune disease. 🩺

 👉 Help us find answers for families like Stella’s: ow.ly/f7xA50XjskH

In our new podcast episode of Medical Minds, you’ll hear from Dr Rachel Galimidi who is at the forefront of biologics drug development and is working to make new and better treatments for a range of diseases. To listen to the full episode, go to Apple or Spotify.


Exciting news! A new clinical trial, DEFINERx050, is testing whether a combo therapy can stop early-stage liver cancer from returning. Co-led by Garvan’s Dr Ankur Sharma & Prof Jacob George (@westmeadinst) Recruiting across 5 states & 12 hospitals.

GarvanInstitute's tweet image. Exciting news! A new clinical trial, DEFINERx050, is testing whether a combo therapy can stop early-stage liver cancer from returning. Co-led by Garvan’s Dr Ankur Sharma & Prof Jacob George (@westmeadinst) Recruiting across 5 states & 12 hospitals.
GarvanInstitute's tweet image. Exciting news! A new clinical trial, DEFINERx050, is testing whether a combo therapy can stop early-stage liver cancer from returning. Co-led by Garvan’s Dr Ankur Sharma & Prof Jacob George (@westmeadinst) Recruiting across 5 states & 12 hospitals.

Half the funding. Half the future. The Medical Research Future Fund was meant to deliver $1B each year – only $650M is reaching researchers. Let’s do what the MRFF was designed for and keep Australian research strong, sustainable and delivering hope. aamri.org.au/mrff

GarvanInstitute's tweet image. Half the funding. Half the future. The Medical Research Future Fund was meant to deliver $1B each year – only $650M is reaching researchers. Let’s do what the MRFF was designed for and keep Australian research strong, sustainable and delivering hope.
aamri.org.au/mrff

For 18 months, doctors couldn’t explain Stella’s severe, recurrent infections. Finally, Garvan researchers helped diagnose her with a rare immune disease. 👉 Help Garvan solve more genetic mysteries: ow.ly/h8cO50Xjqfs

GarvanInstitute's tweet image. For 18 months, doctors couldn’t explain Stella’s severe, recurrent infections. Finally, Garvan researchers helped diagnose her with a rare immune disease.  

👉 Help Garvan solve more genetic mysteries: ow.ly/h8cO50Xjqfs

Inborn errors of immunity are rare diseases caused by single gene disruptions, often leading to severe infections and autoimmunity. Our researchers are fighting to boost the diagnosis rate from 35%➡️70%. 👉 Learn how you can help: ow.ly/1RKO50Xk4Uj


Did you miss out on a place in the 2026 Sydney Marathon? You can still secure one of the limited remaining spots on Team Garvan. Apply today and #Go4Garvan. 👉 Click here: ow.ly/g1vQ50Xjsik

GarvanInstitute's tweet image. Did you miss out on a place in the 2026 Sydney Marathon? 

You can still secure one of the limited remaining spots on Team Garvan. 
Apply today and #Go4Garvan.

👉 Click here: ow.ly/g1vQ50Xjsik

The Goodnow Lab at Garvan has discovered why B cells attack the nerves in the autoimmune disease, MAG neuropathy: they carry genetic changes like those in blood cancers, turning them “rogue”. ow.ly/zJ9150Xi8vi

GarvanInstitute's tweet image. The Goodnow Lab at Garvan has discovered why B cells attack the nerves in the autoimmune disease, MAG neuropathy: they carry genetic changes like those in blood cancers, turning them “rogue”. 

ow.ly/zJ9150Xi8vi
GarvanInstitute's tweet image. The Goodnow Lab at Garvan has discovered why B cells attack the nerves in the autoimmune disease, MAG neuropathy: they carry genetic changes like those in blood cancers, turning them “rogue”. 

ow.ly/zJ9150Xi8vi
GarvanInstitute's tweet image. The Goodnow Lab at Garvan has discovered why B cells attack the nerves in the autoimmune disease, MAG neuropathy: they carry genetic changes like those in blood cancers, turning them “rogue”. 

ow.ly/zJ9150Xi8vi
GarvanInstitute's tweet image. The Goodnow Lab at Garvan has discovered why B cells attack the nerves in the autoimmune disease, MAG neuropathy: they carry genetic changes like those in blood cancers, turning them “rogue”. 

ow.ly/zJ9150Xi8vi

CIRCA is transforming care for rare immune diseases. Through genetic testing and precision diagnosis, this program has cut average patient hospital stays from 68 days to just five! 📉 👉 Help accelerate this research today: ow.ly/2Rrh50XfXOC

GarvanInstitute's tweet image. CIRCA is transforming care for rare immune diseases. Through genetic testing and precision diagnosis, this program has cut average patient hospital stays from 68 days to just five! 📉

👉 Help accelerate this research today: ow.ly/2Rrh50XfXOC

Catch up on our annual breast cancer lecture where you can hear from award-winning researchers and clinicians on the latest advances against breast cancer. Click here: youtu.be/sTG8w8XlXv8?si…

GarvanInstitute's tweet image. Catch up on our annual breast cancer lecture where you can hear from award-winning researchers and clinicians on the latest advances against breast cancer. 

Click here: youtu.be/sTG8w8XlXv8?si…

Missed the deadline for the Sydney Marathon ballot? There is still an opportunity to #Go4Garvan. Be among just 25 runners supporting pioneering medical research at a World Marathon Major. Apply today: ow.ly/GpBz50XeJsq

GarvanInstitute's tweet image. Missed the deadline for the Sydney Marathon ballot? There is still an opportunity to #Go4Garvan. Be among just 25 runners supporting pioneering medical research at a World Marathon Major. 

Apply today: ow.ly/GpBz50XeJsq

Prof Stuart Tangye is a research lead of CIRCA, a Garvan-based collaboration that is transforming the way we tackle #rareimmunedisease. CIRCA’s crucial work is helping clinicians diagnose patients more quickly to guide effective, personalised treatments. ow.ly/cEb050Xbtju

GarvanInstitute's tweet image. Prof Stuart Tangye is a research lead of CIRCA, a Garvan-based collaboration that is transforming the way we tackle #rareimmunedisease. CIRCA’s crucial work is helping clinicians diagnose patients more quickly to guide effective, personalised treatments. ow.ly/cEb050Xbtju

🏃‍♀️ Are you interested in becoming one of 25 gold charity runners for Garvan at the 2026 TCS Sydney Marathon? We’re happy to announce that applications for these Charity Places are now officially open. Click the link to find out more: ow.ly/1jOQ50XbueT

GarvanInstitute's tweet image. 🏃‍♀️ Are you interested in becoming one of 25 gold charity runners for Garvan at the 2026 TCS Sydney Marathon? We’re happy to announce that applications for these Charity Places are now officially open.

Click the link to find out more: ow.ly/1jOQ50XbueT

Loading...

Something went wrong.


Something went wrong.